Administration & Faculty
Amber Buhler, Ph.D.
Assistant Professor
Pharmaceutical Science
Dr. Buhler recently completed a Postdoctoral Internship in Pain Research in the Neuroscience Drug Discovery department at Merck. She completed her Postdoctoral Fellowship in the Department of Pharmacology at the University of Iowa and earned her Ph.D. degree in Pharmacology from the University of Colorado in the areas of pharmacology and neuroscience. Previous degrees include B.A.s in Chemistry and in Functional Biology.
Dr Buhler’s research is currently focused on understanding the function of brainstem pain-modulating centers; areas implicated in chronic pain disorders. This growing field of research is strongly supported by NIH and pharmaceutical sources. Her teaching qualifications include pharmacology, toxicology, neuroscience/neuropharmacology, and neuroanatomy/neurophysiology. She has experience in team teaching techniques as well.
Dr. Buhler’s outside interests include vegetable gardening and Scottish dancing. She collects foam squishy brains and plans to travel the world to discover the best source of dark chocolate.
Current funding
American Association of Colleges of Pharmacy New Investigators Grant
Peer reviewed publications
| 2007 | A.V. Buhler, H.K. Proudfit and G.F. Gebhart. “Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine” accepted to PAIN. |
| 2006 | L. Zhang, K.T. Sykes, A.V. Buhler, D.L. Hammond. “Electrophysiological Heterogeneity of Spinally-Projecting Serotonergic and Non-Serotonergic Neurons in the Rostral Ventromedial Medulla.” Journal of Neurophysiology, 95(3):1853-63. |
| 2005 | A.V. Buhler, J. Choi, H.K. Proudfit and G.F. Gebhart. “Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive.” PAIN, 1016:12-19. |
| 2004 | A.V. Buhler, H.K. Proudfit and G.F. Gebhart. “Two separate populations of rostral ventromedial medulla neurons project to the spinal cord and to the dorsolateral pons in the rat.” Brain Research, 1016:12-19. |
| 2002 | A.V. Buhler, T.V. Dunwiddie. “a7 Nicotinic Acetylcholine Receptors on GABAergic Interneurons Evoke Dendritic and Somatic Inhibition of Hippocampal Neurons.” Journal of Neurophysiology, 87(1):548-557. |
| 2001 | A.V. Buhler, T.V. Dunwiddie. “Regulation of the Activity of Hippocampal Stratum Oriens Interneurons by a7 Nicotinic Acetylcholine Receptors.” Neuroscience, 106 (1):55-67. |
| 1998 | C.J. Frazier, A.V. Buhler, J.L. Weiner, and T.V. Dunwiddie. “Synaptic Potentials Mediated via a-Bungarotoxin-Sensitive Nicotinic Acetylcholine Receptors in Rat Hippocampal Interneurons.” Journal of Neuroscience, 18(20):8228-8235. |
| J.L. Weiner, A.V. Buhler, V.J. Whatley, R.A. Harris, and T.V. Dunwiddie. “Colchicine is a Competitive Antagonist at Human Recombinant gamma-Aminobutyric AcidA Receptors.” Journal of Pharmacology and Experimental Therapeutics, 284:95-102. | |